Top Portland, OR Biotech Companies (26)
Don't see your company?
Create a company profile
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The predictive power of Schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries.
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+ consultants around the world through our Nextcontinent partnership, we work where you do to deliver the change you seek.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours.
UbiVac is a clinical stage biotech engaged in research and development, and manufacture, of therapeutic immune activators, vaccines and cellular immunotherapies to combat cancer. Used in combination with other immunotherapies, UbiVac’s patented technologies have proven highly effective at improving survival and apparent cure in difficult to treat animal cancers (PMID: 27874054; PMID: 31747946; PMID: 22068657). UbiVac believes that the explanation for this effectiveness lies in several high impact publications from 2021 identifying a previously unknown class of shared non-mutated cancer neoantigens that make up as much as 25% of the antigens on cancer cells (PMID: 33740418; PMID: 33691108; PMID: 34663921). As the non-mutated shared cancer neoantigens are short-lived proteins, the majority are expected to be contained in UbiVac’s DPV-001. Importantly, these findings help explain why UbiVac’s immunotherapy provided cross-protective cancer immunity in preclinical models, something that had not been observed in 50 years of study (PMID: 21810919). These remarkable studies raised the possibility of off-the-shelf Universal Cancer Vaccines (PMID: 33852826). UbiVac has completed an NCI-funded phase I/II adjuvant trial of its lead agent, DPV-001. This trial met its endpoints, determined safety, identified drug formulation, and demonstrated proof-of-concept. Based on these data UbiVac partnered with the Providence Cancer Institute and Incyte on a first-in-human immunotherapy trial of UbiVac’s DPV-001, anti-GITR and anti-PD-1 for advanced HNSCC. The first patients were treated in Q4 2021, and preliminary immunological monitoring data will be presented at AACR in April 2022. UbiVac also has a pipeline of cellular therapies under development. Given that UbiVac’s CEO and CSO, together, have 55+ years of experience with preclinical and clinical studies of adoptive immunotherapy, UbiVac is well positioned to bring their innovative cellular therapy platforms to the clinic.
VALIDY corresponds in the information technologies field to the mechanisms that guarantee the integrity of the DNA of a living cell.
Dexcom Corporation is a pioneer and global leader in continuous glucose monitoring (CGM). Dexcom began as a small company with a big dream: To forever change how diabetes is managed. To unlock information and insights that drive better health outcomes. Here we are 25 years later, having pioneered an industry. And we're just getting started. We are broadening our vision beyond diabetes to empower people to take control of health. That means personalized, actionable insights aimed at solving important health challenges. To continue what we've started: Improving human health. We are driven by over 10,000 ambitious, passionate people worldwide who are willing to fight like warriors to earn the trust of our customers by listening, serving with integrity, thinking big, and being dependable. We've already changed millions of lives and we're ready to change millions more. Our future ambition is to become a leading consumer health technology company while continuing to develop solutions for serious health conditions. We'll get there by constantly reinventing unique biosensing-technology experiences. Though we've come a long way from our small company days, our dreams are bigger than ever. The opportunity to improve health on a global scale stands before us
Veana Therapeutics is dedicated to developing innovative, safe, cancer fighting medicines Veana’s VIMO technology is based on orally bioavailable anti-cancer agents that selectively attack and destroy the energy powerhouses (mitochondria) of cancer cells in a fashion that subsequently stimulates the immune system. Veana’s VIMO platform of α-TEA salt form-based products can be combined with other forms of immunotherapy to further improve anti-tumor activity.
Tricol is focused on saving lives through innovation in hemostasis. Stop the bleed! Tricol Biomedical is a fully integrated medical device company that is dedicated to significantly advancing the standard of care in hemostatic and wound care management. Born on the battlefield, our HemCon product line has grown to meet market needs in Trauma Management, Procedural Care and Consumer Self-Care. We are fully committed to quality and innovation in bleeding control and wound care technology.
Circumvent Pharmaceuticals is a Pharmaceuticals company.
FloraWorks is a specialized biotech enterprise discovering rare and novel cannabinoids for commercial and therapeutic applications. We develop and patent scaled manufacturing pathways for cannabinoids with a high potential for therapeutic use while also completing the required toxicology and efficacy research to bring them to market.
Rewire Neuroscience is a Portland, Oregon startup, dedicated to empowering the diverse future of science. We develop intelligent technologies to push forward biomedical research. Our goal is to improve the pace, ease, and reproducibility of research. At Rewire, we are committed to building strength by being a diverse team of leaders, innovators, and risk-takers. We’re all different, and that is what allows us to draw on a range of experiences, backgrounds, and perspectives to grow stronger, together. Rewire is a vocal supporter of race, gender, sexual-orientation, and cultural equality.
Capsa Solutions, Rubbermaid Healthcare, Kirby Lester, and RoboPharma have been fully integrated to form Capsa Healthcare. Collectively, our passion as a single organization is born out of the same commitment and purpose that our customers have to providing superior patient care. We understand the delivery of healthcare cannot wait; our customers rely on our products and support to deliver superior clinical efficiency and medication management accuracy. For acute care facilities, extended care facilities, pharmacies, and central filling operations, we continually invest in product development, technology innovation, service, and support to make sure we are the logical choice for products that elevate the performance of healthcare delivery at every point-of-care. For more than 50 years, Capsa has been a leading developer of mobile storage and technology products that improve user workflow, process efficiency, and healthcare outcomes. Headquartered in Columbus, OH, we operate facilities in Portland, OR, Lake Forest, IL, Huntersville, NC, Waalwijk, The Netherlands, and Agua Prieta, Mexico, and have distribution partners in more than 70 countries.
At BIOTRONIK, patient well-being is our top priority and has been for 60 years. BIOTRONIK is a leading global medical technology company with products and services that save and improve the lives of millions suffering from heart and blood vessel diseases as well as chronic pain. Driven by a purpose to perfectly match technology with the human body, we are dedicated innovators who develop trusted cardiovascular, endovascular and neuromodulation solutions. BIOTRONIK is headquartered in Berlin, Germany, and is represented in over 100 countries. Quality in every detail. From the very start, BIOTRONIK dedicated itself to driving progress and innovation and delivering exceptional quality. We have earned the trust of medical professionals and patients by combining the renowned art of German engineering with technical excellence and uncompromising quality standards. This dedication is evident in everything we do. High achievers are welcome. Medical engineering is an industry of the future. In a field marked by rapid developments and short innovation cycles, the best guarantees for sustainable success are committed, creative, team-oriented specialists, and outstanding leadership. If you are passionate about computer science, engineering or the natural sciences and enjoy developing new ideas, you´ve found the right place. Are you interested? Take a look at our website www.biotronik.com/careers
Personalized health and wellness programs based on human behavior research.
CiiTA is provides expertise and actionable intelligence to pharmaceutical and biotechnology manufacturers.
Elex Biotech Inc is a drug discovery and development company focused on first-in-class new chemical entities (NCEs) for the treatment of arrhythmia and heart failure. Using rational drug design and an internally generated SAR database, the Company has generated ~200 NCEs that stabilize mutant or dysfunctional Ryanodine receptor type 2 (RyR2), the Ca release channel that regulates the strength and frequency of heart muscle contractions. Certain arrhythmias and heart failure share a common defect in Ca handling resulting from RyR2 dysfunction that is addressed by Elex Biotech’s compounds. Elex Biotech has demonstrated in vivo proof of concept in animal models of catecholaminergic polymorphic ventricular tachycardia (CPVT), an orphan disease estimated to cause 15% of unexplained sudden cardiac death in apparently healthy young people.
Galena Biopharma, Inc. is focused on discovering, developing and commercializing innovative therapies.
A Delaware C-corporation that is focused on therapeutic uses of inert gas mixtures.
DesignMedix develops pharmaceutical drugs designed to address the rapid rise in drug resistance in multiple diseases.
Blending technology and science, we develop instrumentation to improve outcomes. Araceli Biosciences delivers high-performance scientific tools for tissue and cell-based biomarker discovery, drug discovery and drug development. With decades of combined biomedical research and instrument design experience, we are focused on developing scientific instrumentation to improve outcomes and enable our customers to advance scientific and medical research. Speed is essential for furthering our understanding of biology, and we believe in reducing the time needed to acquire high-quality data and obtain clear, high-quality results. By making advanced technologies accessible, we allow researchers to focus on the science, not the tool. Our goal is to develop innovative products that accelerate basic research, drug discovery, and manufacturing to advance healthy outcomes. We believe in blurring the line between science and technology, using one to improve the other in a holistic approach. We strive to make the drug discovery process more efficient, reducing the time and bandwidth needed to screen compounds. By pairing fast, easy to use hardware with advanced artificial intelligence analysis algorithms, we aim to transform the drug discovery pipeline, allowing customers to fail faster.
Work Your Passion. Live Your Purpose.
